🎉 M&A multiples are live!
Check it out!

Unicycive Valuation Multiples

Discover revenue and EBITDA valuation multiples for Unicycive and similar public comparables like Pharming, Galapagos, and Vivoryon Therapeutics.

Unicycive Overview

About Unicycive

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.


Founded

2016

HQ

United States of America
Employees

23

Website

unicycive.com

Financials

LTM Revenue $5.9M

LTM EBITDA n/a

EV

$47.7M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Unicycive Financials

Unicycive has a last 12-month revenue of $5.9M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Unicycive achieved revenue of n/a and an EBITDA of -$36.2M.

Unicycive expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Unicycive valuation multiples based on analyst estimates

Unicycive P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $0.7M n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$30.2M -$36.2M XXX XXX XXX
EBITDA Margin -4471% -Infinity% XXX XXX XXX
Net Profit -$18.1M -$30.5M XXX XXX XXX
Net Margin -2675% -Infinity% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Unicycive Stock Performance

As of April 15, 2025, Unicycive's stock price is $1.

Unicycive has current market cap of $73.0M, and EV of $47.7M.

See Unicycive trading valuation data

Unicycive Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$47.7M $73.0M XXX XXX XXX XXX $-0.46

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Unicycive Valuation Multiples

As of April 15, 2025, Unicycive has market cap of $73.0M and EV of $47.7M.

Unicycive's trades at 8.1x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Unicycive's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Unicycive and 10K+ public comps

Unicycive Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $47.7M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -1.3x XXX XXX XXX
P/E -2.0x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -1.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Unicycive Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Unicycive Valuation Multiples

Unicycive's NTM/LTM revenue growth is 1873%

Unicycive's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.4M for the same period.

Over next 12 months, Unicycive's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Unicycive's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Unicycive and other 10K+ public comps

Unicycive Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -100% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 20% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $1.4M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Unicycive Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Unicycive M&A and Investment Activity

Unicycive acquired  XXX companies to date.

Last acquisition by Unicycive was  XXXXXXXX, XXXXX XXXXX XXXXXX . Unicycive acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Unicycive

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Unicycive

When was Unicycive founded? Unicycive was founded in 2016.
Where is Unicycive headquartered? Unicycive is headquartered in United States of America.
How many employees does Unicycive have? As of today, Unicycive has 23 employees.
Who is the CEO of Unicycive? Unicycive's CEO is Dr. Shalabh Gupta, M.D..
Is Unicycive publicy listed? Yes, Unicycive is a public company listed on NAS.
What is the stock symbol of Unicycive? Unicycive trades under UNCY ticker.
When did Unicycive go public? Unicycive went public in 2021.
Who are competitors of Unicycive? Similar companies to Unicycive include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Unicycive? Unicycive's current market cap is $73.0M
What is the current revenue of Unicycive? Unicycive's last 12-month revenue is $5.9M.
What is the current EV/Revenue multiple of Unicycive? Current revenue multiple of Unicycive is 8.1x.
Is Unicycive profitable? Yes, Unicycive is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.